Skip to main content

Table 1 Clinico-pathological features and DNA ploidy status of the series investigated (n=360)

From: Clinical relevance of the reappraisal of negative hormone receptor expression in breast cancer

Variables

N (%)

Grade of differentiation

 

G1

89 (24.7)

G2+G3

271 (75.3)

Tumour size

 

pT1

157 (43.6)

pT2+pT3

203 (56.4)

Nodal status

 

pN0

203 (56.4)

pN1

157 (43.6)

DNA ploidy

 

Diploid

145 (40.3)

Aneuploid

215 (59.7)

  1. N Number of patients.